![Thomas Beck](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Thomas Beck
Voorzitter bij Swedish Pharmaceutical Society
Actieve functies van Thomas Beck
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Swedish Pharmaceutical Society | Voorzitter | - | - |
Loopbaan van Thomas Beck
Eerdere bekende functies van Thomas Beck
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
RECIPHARM AB (PUBL) | Corporate Officer/Principal | 01-01-2015 | 01-10-2021 |
Recipharm Stockholm AB | Directeur/Bestuurslid | 01-01-2010 | 01-01-2015 |
AstraZeneca AB
![]() AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Corporate Officer/Principal | 01-01-1996 | 01-11-2010 |
Vivendi Universal AB
![]() Vivendi Universal AB Publishing: Books/MagazinesConsumer Services Vivendi Universal AB publishes music. | Corporate Officer/Principal | 01-03-2000 | 01-03-2001 |
Opleiding van Thomas Beck
Royal Institute of Technology | Graduate Degree |
Statistieken
Internationaal
Zweden | 7 |
Operationeel
Corporate Officer/Principal | 3 |
Chairman | 1 |
Graduate Degree | 1 |
Sectoraal
Consumer Services | 3 |
Health Technology | 2 |
Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 5 |
---|---|
Recipharm AB
![]() Recipharm AB BiotechnologyHealth Technology Recipharm AB engages in the manufacture of pharmaceuticals and contract development services for pharmaceutical companies. It operates through the following segments: Manufacturing Sterile and Inhalation (MFG-SI); Manufacturing Solids and Others (MFG-SO); Development and Technology (D&T); and Others and Eliminations. The MFG-SI segment includes manufacturing of products on behalf of pharmaceutical companies and covers sterile and inhalation technologies as well as liquid vials and ampoules, lyophilisates, blow-fill-seal products, and inhalation. The MFG-SO segment produces products on behalf of pharmaceutical companies and covers tablets, capsules, semi-solids, and non-sterile liquids. The D&T segment focuses on pharmaceutical development services. The company was founded by Lars Rickard Backsell and Thomas Bengt Eldered in 1995 and is headquartered in Stockholm, Sweden. | Health Technology |
Swedish Pharmaceutical Society | |
Recipharm Stockholm AB | |
AstraZeneca AB
![]() AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Commercial Services |
Vivendi Universal AB
![]() Vivendi Universal AB Publishing: Books/MagazinesConsumer Services Vivendi Universal AB publishes music. | Consumer Services |
- Beurs
- Insiders
- Thomas Beck
- Ervaring